ad image

Biotherapeutics

1 / 1
Concerto Biosciences
Clinical Trials

Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis

Concerto Biosciences

PR-11-24-NI-112Nov 19, 2024
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
Biotherapeutics

Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO

John R. Mosack

Tanvex CDMO

PAO-10-23-CL-05Nov 07, 2023
The Smart Approach to Preclinical Development for Bacterially Expressed Biologics
Biomanufacturing

The Smart Approach to Preclinical Development for Bacterially Expressed Biologics

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

PAO-04-022-CL-13Apr 28, 2022
Advancing a New Class of Immunotherapies
Polyclonal Antibodies

Advancing a New Class of Immunotherapies

SAB Biotherapeutics, Inc.

PAO-04-22-R250-70Apr 21, 2022
Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria
Live Biotherapeutic Products

Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria

Aaron B. Cowley, Ph.D.; Judith Bodette; Brian Duffy

Arranta Bio

PAO-06-21-CL-10Jun 25, 2021
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Clinical Trial Logistics

Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies

Mark Woolf

Catalent

PAO-03-21-CL-06Mar 22, 2021
1 / 1